Chapter 40

  1. Angulo FJ, Getz J, Taylor JP, et al. 1998. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 178:172-177.
  2. Atassi MZ, Oshima M. 1999. Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins. Crit Rev Immunol 19:219-260.
  3. Barr JR, Moura H, Boyer AC, et al. 2005. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis 11:1578-1583.
  4. Barsanti JA. 1984. Botulism, pp 599-607. In Greene CE (ed): Clinical microbiology and infectious diseases of the dog and cat. WB Saunders, Philadelphia.
  5. Barsanti JA. 1990. Botulism, pp 515-520. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  6. Barsanti JA. 1998. Botulism, pp 263-267. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  7. Barsanti JA. 2006. Botulism, pp 389-394. In Greene CE (ed): Infectious diseases of the dog and cat, ed 3. Saunders Elsevier, St Louis.
  8. Barsanti JA, Walser M, Hatheway CL, et al. 1978. Type C botulism in American foxhounds. J Am Vet Med Assoc 172:809-813.
  9. Blakemore WF, Rees-Evans ET, Wheeler PEG. 1977. Botulism in foxhounds. Vet Rec 100:57-58.
  10. Bleck TP. 1995. Clostridium botulinum, pp 2178-2181. In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York.
  11. Bohnel H, Gessler F. 2005. Botulinal toxins—cause of botulism and systemic diseases? Vet Res Commun 29:313-345.
  12. Bruchim Y, Steinman A, Mrakovitz M, et al. 2006. Toxicological, bacteriological and serological diagnosis of botulism in a dog. Vet Rec 158:768-769.
  13. Centers for Disease Control and Prevention. 1998. Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Centers for Disease Control and Prevention, Atlanta (also available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/botulism.pdf).
  14. Chaddock JA, Melling J. 2001. Clostridium botulinum and associated neurotoxins, pp 1141-1152. In Sussman M (ed): Molecular medical microbiology. Academic Press, San Diego.
  15. Coleman ES. 1998. Clostridial neurotoxins: tetanus and botulism. Compend Contin Educ Pract Vet 20:1089-1094.
  16. Collier RJ. 2002. Drug developed for widespread use against botulism. Am Assoc Food Hygiene Vet 26:10.
  17. Cornellissen JMM, Haagsma J, Ven New JJ. 1985. Type C botulism in 5 dogs. J Am Anim Hosp Assoc 21:401-404.
  18. Critchley EM. 1991. A comparison of human and animal botulism: a review. J R Soc Med 84:295-298.
  19. Critchley EM, Hayes PJ, Isaacs RE. 1989. Outbreak of botulism in northwest England and Wales, June. 1989. Lancet 2:849-853.
  20. Darke PGG, Roberts TA, Smart JL, et al. 1976. Suspected botulism in foxhounds. Vet Rec 99:98-99.
  21. Davis LE, Johnson JK, Bickell JM, et al. 1992. Human type A botulism and treatment with 3,4-diaminopyridine. Electromyogr Clin Neurophysiol 32:379-383.
  22. Doellgast GJ, Brown JE, Koufman JA, et al. 1997. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B and E: use of hapten-labeled-antibody elution to isolate specific complexes. J Clin Microbiol 35:578-583.
  23. Doutre MP. 1982. Le botulisme animal de type D au Senegal: premiere observation chez le chien. Rev Elev Med Vet Pays Trop 35:11-14.
  24. Doutre MP: 1983. Seconde observation de botulism de type D chez le chien au Senegal. Rev Elev Med Vet Pays Trop 36:131-132.
  25. 24a. Dux MP, Huang J, Barent R, et al. 2011. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(Hc)] expressed in Pichia pastoris. Protein Exp Purif 75:177-185.
  26. Elad D, Yas-Natan E, Aroch I, et al. 2004. Natural Clostridium botulinum type C toxicosis in a group of cats. J Clin Microbiol 42:5406-5408.
  27. Fain Binda JC, Fernandez RA, Blotta RE, et al. 1998. Natural botulism in dogs due to ingestion of botulinum toxin. Vet Argentina 15:216-221.
  28. Farrow BR, Murrell WG, Revington M, et al. 1983. Type C botulism in young dogs. Aust Vet J 60:374-377.
  29. Fenicia L, Franciosa G, Pourshaban M, et al. 1999. Intestinal toxemia in two young people, caused by Clostridium butyricum type E. Clin Infect Dis 29:1381-1387.
  30. Fernandez RA, Ciccarelli AS. 1999. Botulism: laboratory methods and epidemiology. Anaerobe 5:165-168.
  31. Ferrari ND, Weisse ME. 1995. Botulism. Adv Pediatr Infect Dis 10:81-91.
  32. Franciosa G, Fenicia L, Caldiani C. 1996. PCR for detection of Clostridium botulinum type C in avian and environmental samples. J Clin Microbiol 34:882-885.
  33. Galey FD, Terra R, Walker R, et al. 2000. Type C botulism in dairy cattle from feed contaminated with a dead cat. J Vet Diagn Invest 12:204-209.
  34. Greenwood AG. 1985. Diagnosis and treatment of botulism in lions. Vet Rec 117:58-60.
  35. 33a. Gul N, Smith LA, Ahmed SA. 2010. Light chain separated from the rest of the Type A botulinum neurotoxin molecule is the most catalytically active form. PLoS ONE 5:e12872.4.
  36. Halouzka J, Hubalek Z. 1992. Effect of pH on the stability of type-C toxin of Clostridium botulinum. Folia Microbiol 37:157-158.
  37. 34a. Hadley HS, Wheeler JL, Petersen SW. 2010. Effects of intra-articular botulinum toxin type A (Botox®) in dogs with chronic osteoarthritis. Vet Comp Orthop Traumatol 4:255-258.
  38. Hambleton P. 1992. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 239:16-20.
  39. Hatheway CL. 1995. Botulism: the present status of the disease, pp 55-75. In Montecucco C (ed): Clostridial neurotoxins. Springer, New York.
  40. Herreros J, Schiavo G. 2002. Lipid microdomains are involved in neurospecific binding and internalization of clostridial neurotoxins. Int J Med Microbiol 291:447-453.
  41. Horowitz, BZ. 2005. Botulinum toxin. Crit Care Clin 21:825-839.
  42. Hubalek Z, Halouzka J. 1991. Persistence of Clostridium botulinum type C toxin in blow fly (Calliphoridae) larvae as a possible cause of avian botulism in spring. J Wildl Dis 27:81-85.
  43. Humeau Y, Doussau F, Grant NJ. 2000. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82:427-446.
  44. Jin Y, Takegahara Y, Sugawara Y, et al. 2009. Proteins—differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155:35-45.
  45. Karner J, Allerberger F. 2006. Detecting Clostridium botulinum [letter]. Emerg Infect Dis 12:1292.
  46. Keller MA, Stiehm ER. 2000. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 13:602-614.
  47. 43a. Lew S, Majewski M, Radziszewski P, et al. 2010. Therapeutic efficacy of botulinum toxin in the treatment of urinary incontinence of female dogs. Acta Vet Hung 58:157-165.
  48. Marlow GR, Smart JL. 1982. Botulism in foxhounds. Vet Rec 111:242.
  49. Meyer-Lindenberg A, Wohlfarth KM, Switzer EN. 2003. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog. Aust Vet J 81:612-614.
  50. Middlebrook JL, Brown JE. 1995. Immunodiagnosis and immunotherapy of tetanus and botulism neurotoxins, pp 89-122. In Montecucco C (ed): Clostridial neurotoxins. Springer, New York.
  51. Montecucco C, Schiavo G. 1994. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13:1-8.
  52. Montecucco C, Molgo J. 2005. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 5:274-279.
  53. 48a. Mouttalib S, Khan S, Castel-Lacanal E, et al. 2010. Botulinum toxin A injections for refractory neurogenic detruson activity. BJU Int 106:1677-1680.
  54. Nunn F, Cave TA, Knottenbelt C, et al. 2004. Association between Key-Gaskell syndrome and infection by Clostridium botulinum type C/D. Vet Rec 153:111-115.
  55. Pellizzari R, Rossetto O, Schiavo G, et al. 1999. Tetanus and botulinum neurotoxins: mechanisms of action and therapeutic uses. Philos Trans R Soc Long B Biol Sci 354:259-268.
  56. Popoff MR. 1995. Ecology of neurotoxigenic strains of clostridia, pp 2-29. In Montecucco C (ed): Clostridial neurotoxins. Springer, New York.
  57. Read D, Kelly T. 1990. Botulism in dogs associated with a Waikato wetland area. Surveillance-Wellington 17:9.
  58. Richmond RN, Hatheway C, Kaufman AF. 1978. Type C botulism in a dog. J Am Vet Med Assoc 173:202-203.
  59. Rossetto O, de Bernard M, Pellizzari R, et al. 2000. Bacterial toxins with intracellular protease activity. Clin Chim Acta 291:189-199.
  60. Rossetto O, Seveso M, Caccin P, et al. 2001. Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 39:27-41.
  61. Rossetto O, Morbiato L, Caccin P, et al. 2006.Presynaptic enzymatic neurotoxins. J Neurochem 97:1534-1545.
  62. Sanders DB. 1993. Clinical neurophysiology of disorders of the neuromuscular junction. J Clin Neurophysiol 10:167-180.
  63. Shaari CM, Sanders I, Wu BL, et al. 1995. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 112:566-571.
  64. Shapiro RL, Hatheway C, Swerdlow DL. 1998. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 129:221-228.
  65. 59a. Smith LA. 2009.Botulism and vaccines for its prevention. Vaccine 77: D33-D39.
  66. Thomas RJ. 1991. Detection of Clostridium botulinum types C and D toxin by ELISA. Aust Vet J 68:111-113.
  67. Tjalsma EJ. 1990. Three cases of Clostridium botulinum type C intoxication in the dog. Tijdschr Diergeneeskd 115:518-521.
  68. VanNew JJ. 1986. Electrophysiological evidence of peripheral nerve dysfunction in 6 dogs with botulism type C. Res Vet Sci 40:373-376.
  69. Wallace V, McDowell DM. 1986. Botulism in a dog—first confirmed case in New Zealand. NZ Vet J 34:149-150.
  70. Wang HJ, Tanaka M, Konomi H, et al. 1998. Effect of local injection of botulinum toxin on sphincter of Oddi cyclic motility in dogs. Dig Dis Sci 43:694-701.
  71. Zouari N, Choyakh F, Triki C, et al. 1997. Contribution of electromyography to the diagnosis of botulism. Neurophysiol Clin 27:220-226.